AIC
CBMG

AWM Investment Company’s Cellular Biomedicine Group, Inc. CBMG Stock Holding History

AWM Investment Company’s Portfolio CBMG Stock Details CBMG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-80,165
Closed -$1.32M – 99
2019
Q2 		$1.32M Buy
+80,165
New +$1.31M 0.25% 65

Other funds holding CBMG

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AWM Investment Company's CBMG Position: Q3 2019 in Review

AWM Investment Company sold out of Cellular Biomedicine Group, Inc. (CBMG) in Q3 2019, closing a stake of 80,165 shares — an estimated $1.32M sold.

AWM Investment Company first reported a position in CBMG in Q2 2019 and held it in 1 quarter. The position peaked at $1.32M in Q2 2019. 40 funds tracked by Wall St. Rank hold CBMG as of Q3 2019.

  • AWM Investment Company reported no remaining Cellular Biomedicine Group, Inc. position as of Q3 2019 after selling out during the quarter.
  • AWM Investment Company sold 80,165 Cellular Biomedicine Group, Inc. shares in Q3 2019, an estimated $1.32M.
  • AWM Investment Company first reported a position in Cellular Biomedicine Group, Inc. in Q2 2019 and held it in 1 quarter.
  • AWM Investment Company's Cellular Biomedicine Group, Inc. position peaked at $1.32M in Q2 2019.
  • 40 funds tracked by Wall St. Rank held Cellular Biomedicine Group, Inc. as of Q3 2019.

Based on AWM Investment Company's 13F filing for Q3 2019, filed 12 Nov 2019.